Evaluation of the Quantiplex Human Immunodeficiency Virus Type 1 RNA 3.0 Assay in a Tertiary-Care Center | Zendy

Howard B. Gale | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of the Quantiplex Human Immunodeficiency Virus Type 1 RNA 3.0 Assay in a Tertiary-Care Center

Author(s) -

Howard B. Gale

Publication year - 2000

Publication title -

clinical and diagnostic laboratory immunology

Language(s) - English

Resource type - Journals

eISSN - 1098-6588

pISSN - 1071-412X

DOI - 10.1128/cdli.7.1.122-124.2000

Subject(s) - bdna test , virology , tertiary care , human immunodeficiency virus (hiv) , rna , virus , microbiology and biotechnology , biology , medicine , viral load , chemistry , biochemistry , gene

The Quantiplex human immunodeficiency virus type 1 RNA 3.0 Assay (bDNA) (Bayer Diagnostics, Walpole, Mass.) produced linear and reproducible (intra-assay and interassay) results over its quantification range of 50 to 500,000 copies/ml of plasma with 96% specificity. A threefold or 0.5-log10 change or greater was clinically significant for serial patient samples.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research